Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MMP12 | P39900 | 1/20 | 0.45 |
| ▸ | TGM2 | P21980 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | P4HB | P07237 | 1/20 | 0.44 |
| ▸ | PDIA4 | P13667 | 1/20 | 0.44 |
| ▸ | PDIA3 | P30101 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20035072 | 0.89 | P4HB (0.53) | LMNAKMT2ACYP3A4CYP2C9TSHR | |
| SCHEMBL20035071 | 0.89 | P4HB (0.53) | LMNAKMT2ACYP3A4CYP2C9TSHR | |
| SCHEMBL18136409 | 0.89 | P4HB (0.53) | LMNAKMT2ACYP3A4CYP2C9TSHR | |
| SCHEMBL16710235 | 0.89 | P4HB (0.53) | LMNAKMT2ACYP3A4CYP2C9TSHR | |
| SCHEMBL16710218 | 0.88 | TSHR (0.55) | LMNAKMT2ACYP3A4CYP2C9TSHR | |
| SCHEMBL20633948 | 0.88 | TSHR (0.55) | LMNAKMT2ACYP3A4CYP2C9TSHR | |
| SCHEMBL18134222 | 0.84 | TSHR (0.47) | LMNAALDH1A1POLBKMT2ACYP3A4 | |
| SCHEMBL23480052 | 0.83 | LMNA (0.64) | LMNAALDH1A1POLBKMT2AKDM4E | |
| SCHEMBL30578065 | 0.83 | LMNA (0.64) | LMNAALDH1A1POLBKMT2AKDM4E | |
| SCHEMBL18134221 | 0.83 | P4HB (0.47) | LMNAALDH1A1POLBKMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10443084-B2 | Naphthalene derived chromogenic enzyme substrates | GLYCOSYNTH LIMITED (GB) | 2019-10-15 | — | — | US | disclosed |
| US-9938562-B2 | Naphthalene derived chromogenic enzyme substrates | GLYCOSYNTH LIMITED (GB) | 2018-04-10 | — | — | US | disclosed |
| US-9938562-B2 | Naphthalene derived chromogenic enzyme substrates | GLYCOSYNTH LIMITED (GB) | 2018-04-10 | — | — | US | disclosed |
| US-20160298167-A1 | NAPHTHALENE DERIVED CHROMOGENIC ENZYME SUBSTRATES | GLYCOSYNTH LIMITED (GB) | 2016-10-13 | — | — | US | disclosed |
| US-20160298167-A1 | NAPHTHALENE DERIVED CHROMOGENIC ENZYME SUBSTRATES | GLYCOSYNTH LIMITED (GB) | 2016-10-13 | — | — | US | disclosed |
| WO-2015067927-A1 | NAPHTHALENE DERIVED CHROMOGENIC ENZYME SUBSTRATES | GLYCOSYNTH LIMITED (GB) | 2015-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10443084-B2 | Naphthalene derived chromogenic enzyme substrates | MGAM, UGDH, ME1 | LMNA 2098/4885ALDH1A1 669/4885POLB 2235/4885 |
| US-20160298167-A1 | NAPHTHALENE DERIVED CHROMOGENIC ENZYME SUBSTRATES | CYP2R1, TDO2, XDH | LMNA 1727/4885ALDH1A1 929/4885POLB 2406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.